Creatine and Creatinine Metabolism - Physiological Reviews

1208 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
946. STÖCKLER S, HANEFELD F, AND FRAHM J. Creatine replacement
therapy in guanidinoacetate methyltransferase deficiency, a
novel inborn error of metabolism. Lancet 348: 789–790, 1996.
947. STÖCKLER S, HOLZBACH U, HANEFELD F, MARQUARDT I,
HELMS G, REQUART M, HÄNICKE W, AND FRAHM J. Creatine
deficiency in the brain: a new, treatable inborn error of metabolism.
Pediatr Res 36: 409–413, 1994.
948. STÖCKLER S, ISBRANDT D, HANEFELD F, SCHMIDT B, AND
VON FIGURA K. Guanidinoacetate methyltransferase deficiency:
the first inborn error of creatine metabolism in man. Am J Hum
Genet 58: 914–922, 1996.
949. STÖCKLER S, MARESCAU B, DE DEYN PP, TRIJBELS JMF, AND
HANEFELD F. Guanidino compounds in guanidinoacetate methyltransferase
deficiency, a new inborn error of creatine synthesis.
Metabolism 46: 1189–1193, 1997.
950. STOKES GS, NORRIS LA, MARWOOD JF, JOHNSTON H, AND
CATERSON RJ. Effect of dialysis on circulating Na,K ATPase
inhibitor in uremic patients. Nephron 54: 127–133, 1990.
951. STOREY KB. Purification and properties of adductor muscle phosphofructokinase
from the oyster, Crassostrea virginica. The aerobic/anaerobic
transition: role of arginine phosphate in enzyme
control. Eur J Biochem 70: 331–337, 1976.
952. STOUT J, ECKERSON J, NOONAN D, MOORE G, AND CULLEN D.
Effects of 8 weeks of creatine supplementation on exercise performance
and fat-free weight in football players during training.
Nutr Res 19: 217–225, 1999.
953. STRACKE ML, AZNAVOORIAN S, MULVANEY PT, AND LIOTTA
LA. Tumor cell motility and invasion. In: Encyclopedia of Cancer,
edited by J. R. Bertino. Orlando, FL: Academic, 1997, p. 1855–1867.
954. STROUD MA, HOLLIMAN D, BELL D, GREEN AL, MACDONALD
IA, AND GREENHAFF PL. Effect of oral creatine supplementation
on respiratory gas exchange and blood lactate accumulation during
steady-state incremental treadmill exercise and recovery in
man. Clin Sci 87: 707–710, 1994.
955. SU C-Y, PAYNE M, STRAUSS AW, AND DILLMANN WH. Selective
reduction of creatine kinase subunit mRNAs in striated muscle of
diabetic rats. Am J Physiol Endocrinol Metab 263: E310–E316,
1992.
956. SUGIMURA T, SATO S, OHGAKI H, TAKAYAMA S, NAGAO M,
AND WAKABAYASHI K. Mutagens and carcinogens in cooked
food. In: Genetic Toxicology of the Diet, edited by I. Knudsen.
New York: Liss, 1986, p. 85–107.
957. SUN AY AND CHEN Y-M. Oxidative stress and neurodegenerative
disease. J Biomed Sci 5: 401–414, 1998.
958. SUZUKI H. Sarcosine oxidase: structure, function, and the application
to creatinine determination. Amino Acids 7: 27–43, 1994.
959. SUZUKI K, SAGAI H, IMAMURA S, AND SUGIYAMA M. Cloning,
sequencing, and overexpression in Escherichia coli of a sarcosine
oxidase-encoding gene linked to the Bacillus creatinase gene. J
Ferment Bioeng 77: 231–234, 1994.
960. SUZUKI K, SAGAI H, SUGIYAMA M, AND IMAMURA S. Molecular
cloning and high expression of the Bacillus creatinase gene in
Escherichia coli. J Ferment Bioeng 76: 77–81, 1993.
961. SUZUKI T AND FURUKOHRI T. Evolution of phosphagen kinase.
Primary structure of glycocyamine kinase and arginine kinase
from invertebrates. J Mol Biol 237: 353–357, 1994.
962. SUZUKI YJ, EDMONDSON JD, AND FORD GD. Inactivation of
rabbit muscle creatine kinase by hydrogen peroxide. Free Radical
Res Commun 16: 131–136, 1992.
963. SWAIN JL, SABINA RL, MCHALE PA, GREENFIELD JC, AND
HOLMES EW. Prolonged myocardial nucleotide depletion after
brief ischemia in the open-chest dog. Am J Physiol Heart Circ
Physiol 242: H818–H826, 1982.
964. SWEENEY HL. The importance of the creatine kinase reaction:
the concept of metabolic capacitance. Med Sci Sports Exercise 26:
30–36, 1994.
965. SYLLM-RAPOPORT I, DANIEL A, STARCK H, GÖTZE W,
HARTWIG A, GROSS J, AND RAPOPORT S. Creatine in red cells:
transport and erythropoietic dynamics. Acta Biol Med Germ 40:
653–659, 1981.
966. SYLVÉN C, KALLNER A, HENZE A, LARSEN F, LISKA J, AND
MOGENSEN L. Release pattern of CK-MB and mitochondrial CK
following myocardial ischaemia. Clin Chim Acta 151: 111–119,
1985.
967. SYLVÉN C, LIN L, JANSSON E, SOTONYI P, FU L-X, WAAGSTEIN
F, HJALMARSSON Å, MARCUS C, AND BRÖNNEGÅRD M. Ventricular
adenine nucleotide translocator mRNA is upregulated in
dilated cardiomyopathy. Cardiovasc Res 27: 1295–1299, 1993.
968. SZULMAJSTER J. Bacterial degradation of creatinine. II. Creatinine
desimidase. Biochim Biophys Acta 30: 154–163, 1958.
969. TAKANO Y, AOIKE I, GEIYO F, AND ARAKAWA M. Urinary excretion
rate of guanidinoacetic acid as a new marker in hypertensive
renal damage. Nephron 52: 273–277, 1989.
970. TAKATA Y, DATE T, AND FUJIOKA M. Rat liver guanidinoacetate
methyltransferase. Proximity of cysteine residues at positions 15,
90 and 219 as revealed by site-directed mutagenesis and chemical
modification. Biochem J 277: 399–406, 1991.
971. TAKATA Y AND FUJIOKA M. Identification of a tyrosine residue in
rat guanidinoacetate methyltransferase that is photolabeled with
S-adenosyl-L-methionine. Biochemistry 31: 4369–4374, 1992.
972. TAKATA Y AND FUJIOKA M. Recombinant rat guanidinoacetate
methyltransferase: study of the structure by trace labeling lysine
residues with acetic anhydride. Int J Biochem 22: 1333–1339,
1990.
973. TAKATA Y, KONISHI K, GOMI T, AND FUJIOKA M. Rat guanidinoacetate
methyltransferase. Effect of site-directed alteration of
an aspartic acid residue that is conserved across most mammalian
S-adenosylmethionine-dependent methyltransferases. J Biol
Chem 269: 5537–5542, 1994.
974. TAKEDA M, JUNG KY, ENDOU H, AND KOIDE H. Intranephron
distribution of creatine content in rats. Biochem Mol Biol Int 32:
435–440, 1994.
975. TAKEDA M, KIYATAKE I, KOIDE H, JUNG KY, AND ENDOU H.
Biosynthesis of guanidinoacetic acid in isolated renal tubules. Eur
J Clin Chem Clin Biochem 30: 325–331, 1992.
976. TAKEDA M, KOIDE H, JUNG KY, AND ENDOU H. Intranephron
distribution of glycine-amidinotransferase activity in rats. Renal
Physiol Biochem 15: 113–118, 1992.
977. TAKEDA M, NAKAYAMA S, TOMINO Y, JUNG KY, ENDOU H, AND
KOIDE H. Heterogeneity of transamidinase activity and creatine
content along the rat nephron. In: Guanidino Compounds in
Biology and Medicine, edited by P. P. De Deyn, B. Marescau, V.
Stalon, and I. A. Qureshi. London: Libbey, 1992, p. 153–157.
978. TAKEMURA K, AOYAGI K, NAGASE S, GOTOH M, HIRAYAMA A,
UEDA A, TOMIDA C, AND KOYAMA A. Biosynthesis of methylguanidine
in the hepatic peroxisomes and the effect of the induction
of peroxisomal enzymes by clofibrate. Nephron 78: 82–87, 1998.
979. TAKEMURA K, AOYAGI K, NAGASE S, SAKAMOTO M, ISH-
IKAWA T, AND NARITA M. Effect of hyperbaric oxygen therapy on
urinary methylguanidine excretion in patients with or without
renal failure. In: Guanidino Compounds in Biology and Medicine,
edited by P. P. De Deyn, B. Marescau, V. Stalon, and I. A.
Qureshi. London: Libbey, 1992, p. 301–307.
980. TAKEMURA K, NAGASE S, AOYAGI K, GOTOH M, KOYAMA A,
AND NARITA M. Biosynthesis of guanidine in isolated rat hepatocytes,
perfused rat liver and intact animals. Nephron 67: 334–339,
1994.
981. TAMIR Y AND BENGAL E. p53 protein is activated during muscle
differentiation and participates with MyoD in the transcription of
muscle creatine kinase gene. Oncogene 17: 347–356, 1998.
982. TANABE Y, ESAKI K, AND NOMURA T. Skeletal muscle pathology
in X chromosome-linked muscular dystrophy (mdx) mouse. Acta
Neuropathol 69: 91–95, 1986.
983. TANAKA T, OHIRA Y, DANDA M, HATTA H, AND NISHI I. Improved
fatigue resistance not associated with maximum oxygen
consumption in creatine-depleted rats. J Appl Physiol 82: 1911–
1917, 1997.
984. TAO Q-F, SOSZYNSKI PA, HOLLENBERG NK, AND GRAVES SW.
Specificity of the volume-sensitive sodium pump inhibitor isolated
from human peritoneal dialysate in chronic renal failure. Kidney
Int 49: 420–429, 1996.
985. TARNOPOLSKY M AND MARTIN J. Creatine monohydrate increases
strength in patients with neuromuscular disease. Neurology
52: 854–857, 1999.
986. TARNOPOLSKY MA, ROY BD, AND MACDONALD JR. A random-